Verastem | VSTM - Des Atouts

Prix De L'Action
6.05
Variation Quotidienne
0.39 6.87%
Mensuellement
4.11%
Annuel
25.75%
Q2 Prévisions
5.17




Des Atouts Changement Date
AbbVie USD 133.96B 62M 2025-12
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
AstraZeneca USD 114.07B 382M 2025-12
Curis USD 19.97M 9.27M 2025-12
Cytokinetics USD 1.42B 12.02M 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
Incyte USD 6.96B 627.62M 2025-12
Laboratory Of America USD 18.39B 131.1M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
TG Therapeutics USD 1.06B 38.23M 2025-12
Verastem USD 246.44M 69.59M 2025-12